- Home
- ASB vs SLNO Comparison
ASB vs SLNO Comparison
Compare ASB & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- SLNO
- Stock Information
- Founded
- ASB 1861
- SLNO 1999
- Country
- ASB United States
- SLNO United States
- Employees
- ASB N/A
- SLNO N/A
- Industry
- ASB Major Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ASB Finance
- SLNO Health Care
- Exchange
- ASB Nasdaq
- SLNO Nasdaq
- Market Cap
- ASB 4.4B
- SLNO 3.8B
- IPO Year
- ASB N/A
- SLNO 2014
- Fundamental
- Price
- ASB $26.49
- SLNO $62.37
- Analyst Decision
- ASB Hold
- SLNO Strong Buy
- Analyst Count
- ASB 11
- SLNO 9
- Target Price
- ASB $27.64
- SLNO $116.78
- AVG Volume (30 Days)
- ASB 1.4M
- SLNO 2.7M
- Earning Date
- ASB 10-23-2025
- SLNO 11-05-2025
- Dividend Yield
- ASB 3.48%
- SLNO N/A
- EPS Growth
- ASB N/A
- SLNO N/A
- EPS
- ASB 0.78
- SLNO N/A
- Revenue
- ASB $1,035,964,000.00
- SLNO $32,656,999.00
- Revenue This Year
- ASB $56.79
- SLNO N/A
- Revenue Next Year
- ASB $5.69
- SLNO $181.85
- P/E Ratio
- ASB $33.75
- SLNO N/A
- Revenue Growth
- ASB 3.82
- SLNO N/A
- 52 Week Low
- ASB $18.32
- SLNO $41.50
- 52 Week High
- ASB $28.18
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- ASB 57.34
- SLNO 48.83
- Support Level
- ASB $25.18
- SLNO $55.78
- Resistance Level
- ASB $26.18
- SLNO $68.46
- Average True Range (ATR)
- ASB 0.53
- SLNO 4.12
- MACD
- ASB 0.01
- SLNO 0.71
- Stochastic Oscillator
- ASB 74.45
- SLNO 67.58
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.